Pure Global AI
ANVISA registration 80000230101Valid until Oct 24, 2035

IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS

ANVISA Registration Number: 80000230101AGILENT TECHNOLOGIES BRASIL LTDAAGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.Risk Class III
Verified
Device names
Technical name
IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS
View exact technical-name matches →
PT: IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DE CÉLULAS GERMINATIVAS
Commercial name
MARCADOR TUMORAL DE CÉLULAS GERMINATIVAS
View exact commercial-name matches →
Risk class
Class III
Registration details
Registration Number
80000230101
Process Number
25351134866202521
CNPJ
03290250000100
Company information
Registration Holder
AGILENT TECHNOLOGIES BRASIL LTDA
Manufacturer
AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.
Manufacturing Country
Singapore
PT: SINGAPURA, REPÚBLICA DA
Dates and status
Publication Date
Oct 24, 2025
Validity
24/10/2035
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for IMMUNOHISTOCHEMISTRY - GERM CELL CARCINOMA MARKERS in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80000230101 and manufactured by AGILENT TECHNOLOGIES SINGAPORE (INTERNATIONAL) PTE LTD.. The registration is held by AGILENT TECHNOLOGIES BRASIL LTDA with validity until Oct 24, 2035.

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.